Improving the therapy of generalized forms of Meningococcal infection in children using extracorporeal hemocorrection

Invasive meningococcal infection is a significant cause of death, reaching 80% in septic shock. The Pediatric Research and Clinical Center for Infectious Diseases (PRCCID) has developed an algorithm for the treatment of children with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome, which includes basic drug therapy with polymyxin hemoperfusion in combination with extended methods of extracorporeal hemocorrection.

Purpose: to evaluate the effectiveness of extracorporeal hemocorrection operations in children with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome.

Materials and research methods: to the intensive care unit of the PRCCID for the analyzed period 2006—2020 34 children were hospitalized with invasive meningococcal infection with refractory septic shock and multiple organ failure syndrome. Two groups were formed: Group 1 — children admitted to the PRCCID in the period 2014—2020 (n = 23), who underwent polymyxin hemoperfusion simultaneously with extended methods of extracorporeal hemocorrection, group 2 — children hospitalized in 2006—201 3 (n = 1 1), methods of extracorporeal hemocorrection were not performed. The Mann-Whitney U-test and ANOVA were used to evaluate the results.

Results and discussion: the use of extracorporeal hemocorrection operations in the complex therapy of invasive forms of meningococcal infection with refractory septic shock and multiple organ failure syndrome in children provides stabilization of central hemodynamics, reduces clinical and laboratory inflammatory reactions, helps to reduce the dose of vasopressor drugs and parameters of respiratory support, and also increases patient survival rate by 82.6%.

1. Скрипченко Н.В., Вильниц А.А. Менингококковая инфекция у детей. Санкт-Петербург: Тактик-Студио, 2015:840.

2. [Skripchenko N.V, Vil'nits A.A. Meningococcal infection in children. St. Petersburg: Taktik-Studio,2015:840. (In Russ.)]

3. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2019: State report. M.: Fed-eral'naya sluzhba po nadzoru v sfere zashchity prav potrebitelei i blagopoluchiya cheloveka=Federal Service for Surveillance on Consumer Rights Protection and Human Welfare. 2020:299. (In Russ.)

4. Brandtzaeg P., van Deuren M. Classification and pathogenesis of meningococcal infections. Methods Mol Biol. 2012; 799:21—35. doi: 10.1007/978-1-61779-346-2_2.

5. Rhodes A., Evans L.E., Alhazzani W, Levy M.M. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Mar; 43(3):304— 377. doi: 10.1007/s00134-017-4683-6. Epub 2017 Jan 18.

6. Weiss S.L., Peters MJ., Alhazzani W, Agus M.S.D. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020 Feb; 46(Suppl 1): 10—67. doi: 10.1007/s001 34-019-05878-6.

7. Beloborodov V.B. Unresolved issues of meningococcal infection. Infektsionnye Bolezni. Novosti. Mneniya. Obuchenie=Infectious Diseases. News. Opinions. Training. 2018; 1:46—53 (In Russ.)

8. Brusletto B.S., Hellerud B.C., Lоberg E.M., Goverud I.L., Vege A., Berg J.P., Brandtzaeg P., Оvstebо R. Traceability and distribution of Neisseria meningitidis DNA in archived post mortem tissue samples from patients with systemic meningococcal disease. BMC Clin Pathol. 2017 Aug 16; 17:10. doi: 10.1186/s12907-017-0049-9. eCollection 2017.

9. Darton T., Guiver M., Naylor S., Jack D.L., Kaczmarski E.B., Borrow R., Read R.C.. Severity of meningococcal disease associated with genomic bacterial load. Clin Infect Dis. 2009 Mar 1; 48(5):587— 94. doi: 10.1086/596707.

10. Hackett SJ., Guiver M., Marsh J., Sills J.A., Thomson A.P., Kaczmarski E.B., Hart C.A. Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child. 2002; 86(1):44— 6.

11. Ovstebo R., Brandtzaeg P., Brusletto B., Haug K.B., Lande K., Hoiby E.A., Kierulf P. Use of robotized DNA isolation and real-time pcr to quantify and identify close correlation between levels of neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol. 2004; 42(7):2980—7.

12. Rosa S.D., Villa G., Ronco C. The golden hour of polymyxin B he-moperfusion in endotoxic shock: The basis for sequential extracorporeal therapy in sepsis. Artif Organs. 2020 Feb; 44(2):184—1 86. doi: 10.1111/aor.13550. Epub 2019 Sep 2.

13. Lobzin Yu.V., Ivanova M.V, Skripchenko N.V., Vil'nits A.A., Karev VE., Gorelik E.YU., Serednyakov K.V., Konev A.I. Modern clinical and epidemiological features of the course of generalized meningococcal infection and new treatment options. Infektsionnye Bolezni: novosti, mneniya, obuchenie=Infectious Diseases: News, Opinions, Education. 2018; 7; 1(24):69—77 (In Russ.)

14. Carcillo Joseph A. Multiple Organ System Extracorporeal Support in Critically Ill Children. Pediatr Clin N Am. 2008; 55:617—646.

15. Gomez-Jimenez J., Salgado A., Mourelle M., Martin M.C., Segura R.M., Peracaula R., Moncada S. L-arginin: nitric oxide pathway in endo-toxemia and human septic shock. Crit. Care Med. 1995; 23(2):253—258. doi: 10.1097/00003246-199502000-00009.

16. Theilen U., Wilson L., Wilson G., Beattie J.O., Qureshi S, Simpson D. Management of invasive meningococcal disease in children and young people: summary of SIGN guidelines. BMJ. 2008; 336(7657): 1367—1370.

17. Pelkonen T., Roine I., Cruzeiro M.L., Pitkaranta A., Kataja M., Pelto-la H. Slow initial P-lactam infusion and oral paracetamol to treat childhood bacterial meningitis:a randomised, controlled trial. The Lancet. Inf. Dis., 2011; 11 (8):613—621. doi: 10.1016/S1473-3099(11)70055-X

18. Zagli G., Bonizzoli M., Spina R., Cianchi G., Pasquini A., Anichini V, Matano S., Tarantini F, Di Filippo A., Maggi E., Peris A. Efects of hemoperfusion with an immobilized polymyxin-B fber column on cytokine plasma levels in patients with abdominal sepsis. Minerva Anestesiol. 2010; (76):405—12.

19. Nishibori M., Takahashi H.K., Katayama H., Mori S., Saito S., Iwa-gaki H., Tanaka N., Morita K., Ohtsuka A. Specifc removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized flter column. Acta Med. Okayama. 2009; (63):65—9. PMID: 19247424. doi: 10.18926/AMO/31855.

20. Tanaka Y., Okano K., Tsuchiya K., Yamamoto M., Nitta K.. Polymyxin B. Hemoperfusion improves hemodynamic status in patients with sepsis with both gram-negative and non-gram-negative bacteria. J. Clin. Exp. Nephrol., 2015; (1):4. DOI: 10.21767/2472—5056.100004

21. Vatazin A.V, Zulkarnaev A.B., Krstich M. Effect of selective adsorption of endotoxin on mortality. Abstracts of the Scientific-Practical Conference «Actual Questions of Nephrology, Dialysis, Surgical Correction and Hemodialysis». Moscow, 2011:10.

22. Ishibe Y., Shibata S., Takahashi G., Suzuki Y., Inoue Y., Endo S. Association of type II secretory phospholipase A2 and surfactant protein D with the pulmonary oxygenation potential in patients with septic shock during polymyxin-B immobilized fiber-direct hemoperfusion. J. Clin. Apher. Oct 2017; 32(5):302—10. DOI: 10.1002/jca.21507. PMID:27623356.

23. Lobzin Yu.V, Skripchenko N.V., Serednyakov K.V., Markova K.V Method of treating a generalized form of meningococcal infection in children with refractory septic shock and multiple organ failure syndrome. Patent na izobretenie=Patent for invention RU 2712050 C1, 24.01.2020. Application No. 2019123073 dated 17.07.2019 (In Russ.)

24. Marshall J.C., Foster D., Vincent J.L., Cook DJ., Cohen J., Dellinger R.P., Opal S., Abraham E., Brett S.J., Smith T., Mehta S., Derzko A., Ro-maschin A., MEDIC study. Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study. J Infect Dis. 2004; 190(3):527—34. doi: 10.1086/422254. Epub 2004 Jul 2.

25. Terayama T., Yamakawa K., Umemura Y., Aihara M., Fujimi S. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis. Surg Infect (Larchmt). 2017; 18(3):225—233. doi: 10.1089/sur.2016.168. Epub 2017 Jan 16.